Real preparation runs four to eight weeks and has four tracks: medical screening (a 12-lead ECG and bloodwork, reviewed by your provider's physician), a supervised medication plan (tapering interacting drugs, switching long-acting opioids to short-acting ones), physical basics (electrolytes, hydration, sleep, provider dietary rules), and psychological groundwork (intentions, somatic practice, and support lined up for after).
None of this is optional garnish. Preparation is where most of ibogaine's controllable risk actually gets controlled.
Every clinician we interviewed for the course said some version of the same thing: the people who struggle most are usually the ones who treated treatment like a flight to catch instead of a process to enter. And the preparation weeks are not just risk management. As Dr. Moller puts it in the lesson below, for people coming off substances the taper period is already part of the treatment: your body is giving up its regulation strategy before it has been handed a new one, and how you are supported through that gap shapes everything after.
The medical track: screening and full disclosure
A serious provider starts working you up weeks before you fly (if yours has not asked for any of this, stop and read the clinic guide before going further):
- A 12-lead ECG, with the QTc interval calculated and reviewed by their physician. This is the single test most capable of catching the people for whom ibogaine is deadly, for reasons covered in the safety guide.
- Bloodwork: potassium and magnesium (low levels amplify cardiac risk and get corrected before treatment), plus liver and kidney function, which affect how you process the drug.
- A complete medical history, including every medication, supplement, and substance you use. This only works if you hide nothing. People omit benzodiazepines, alcohol, kratom, or "just occasional" stimulant use out of shame, and every omission is a variable the physician cannot manage. The provider is not there to judge you. They are there to keep you alive, and they can only manage what they know about.
The medication track: tapers take weeks, not days
Many common medications interact with ibogaine, some dangerously. Anything that prolongs the QT interval stacks with ibogaine's cardiac effect, and that list includes certain antidepressants, antipsychotics, antibiotics, and anti-nausea drugs. SSRIs and other serotonergic drugs add a second concern on top. Stimulants raise cardiac load. Every one of these needs a supervised plan made with your provider and, ideally, the prescriber who knows you.
For opioid users there is a specific, non-negotiable sequence: long-acting drugs like methadone and buprenorphine must be switched to short-acting opioids for a period of weeks before treatment, because they blunt the treatment and complicate the risk picture. Timing of your last dose gets choreographed with the provider. And through all of it, do not white-knuckle a taper alone to "arrive clean." Arriving stabilized on a short-acting opioid per your provider's protocol is correct; arriving three days into unsupervised withdrawal with wrecked electrolytes is dangerous. The full addiction-specific picture is in the opioid guide.
Stopping antidepressants, benzodiazepines, or maintenance opioids abruptly carries its own serious risks, up to and including seizures and suicide risk. Every taper in this article happens on a schedule built with medical professionals. If a provider tells you to figure the tapering out yourself, that is a red flag about the provider.
The body track: boring, and it saves lives
The glamorous version of preparation is spiritual. The version that changes outcomes is mostly maintenance: eat properly and keep electrolytes up (this is why providers care about your potassium and magnesium), hydrate, and protect sleep in the final weeks as best your situation allows. Follow your provider's dietary instructions exactly, including pre-treatment fasting rules, which exist partly to manage the nausea described in the experience guide. Skip alcohol entirely in the run-up, ask your provider about caffeine, and do not add new supplements without clearing them, because "natural" does not mean non-interacting.
The mind track: intentions and a regulated nervous system
Jimena's observation from years of receiving patients is the whole argument for this section: most people arrive with a nervous system already stuck in overdrive, hypervigilant and depleted, and then ask a 30-hour experience to sort it out. The work is to arrive with some capacity already built. In practice that means a daily somatic practice in the weeks before, breathwork, grounding exercises, gentle movement, anything that teaches your body it can settle, so that when something difficult surfaces mid-journey, settling is a skill you already own rather than one you are improvising.
On intentions: set them, hold them loosely. Write down what you want to understand or change, journal honestly about what you expect and what you fear, and then let go of the script. Ibogaine has a reputation for showing people what they need rather than what they ordered, and clinging to a planned storyline mid-experience is a recipe for struggle. Come with questions, not demands.
The logistics track: build the landing before you take off
Book the aftercare before the treatment. I mean that literally: the days-to-weeks afterglow window is the most valuable real estate in this whole process, and people routinely arrive home into it with no plan (the full playbook is in the integration guide). Before you fly: clear two to four weeks of obligations, arrange a companion or at minimum a pickup and first days of support at home, schedule your first integration sessions, tell someone you trust exactly where you are going, and plan a gentle re-entry, not a Monday morning back at full speed. If you are coming off opioids, your relapse-risk plan for the weeks after gets built now too, while your judgment is at its best.
Key takeaways
- Start four to eight weeks out. Real preparation cannot be compressed into the week before your flight.
- Screening plus honesty: the ECG and bloodwork only protect you if your provider knows everything you actually take.
- Tapers are choreographed, never improvised: long-acting opioids switch to short-acting weeks ahead, interacting medications wind down on a supervised schedule.
- Arrive regulated, not wrecked: somatic practice, sleep, and nutrition are performance and safety factors, not wellness garnish.
- Book the aftercare before the treatment. The afterglow window opens whether or not you built anything to catch it.
Frequently asked questions
How long before ibogaine treatment should I start preparing?
Four to eight weeks is a realistic runway once a provider accepts you: enough time for screening, any medication tapers, a daily somatic practice to take hold, and logistics. Complicated medication situations, especially methadone or buprenorphine, can need longer.
Do I have to stop my antidepressants before ibogaine?
Usually yes, on a supervised taper. Serotonergic drugs and several QT-prolonging psychiatric medications interact with ibogaine, and providers require a washout period. Never stop them abruptly or on your own; the taper schedule belongs to your prescriber and provider together.
Can I drink coffee or alcohol before treatment?
Alcohol should stop entirely in the weeks before treatment; it stresses the same systems ibogaine will and undermines sleep and electrolytes. Caffeine is a provider-specific rule, typically restricted in the final days. Follow your provider's instructions over any general guide, including this one.
What if I cannot fully taper off opioids before treatment?
You are not expected to arrive detoxed; that is what the treatment is for. The requirement is arriving on short-acting opioids per your provider's protocol, with long-acting drugs like methadone switched over well in advance. Never attempt an unsupervised cold-turkey to arrive "clean."
Sources
- Dickinson J, et al. "Clinical guidelines for ibogaine-assisted detoxification." Global Ibogaine Therapy Alliance (GITA), 2015.
- Koenig X, Hilber K. "The anti-addiction drug ibogaine and the heart: a delicate relation." Molecules, 2015;20(2):2208-2228.
- Alper KR, Stajić M, Gill JR. "Fatalities temporally associated with the ingestion of ibogaine." Journal of Forensic Sciences, 2012;57(2):398-412.